A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

Trial Profile

A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 20 Mar 2017

At a glance

  • Drugs Tc 99m tilmanocept (Primary)
  • Indications Anal cancer; Squamous cell cancer
  • Focus Diagnostic use
  • Sponsors Cardinal Health
  • Most Recent Events

    • 28 Nov 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 08 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top